Journals / Turkish Journal of Hematology / 2011 / Cilt: 28 - Sayı: 2

Paclitaxel therapy and immune thrombocytopenic purpura: Coincidence or association?

Paclitaxel tedavisi ve immun trombositopeni: Rastlantı mı, ilişki mi?

Pages
151–152
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
🔖

Cite This Article

ALTUNTAŞ, F., ÜYETÜRK, Ü., ARSLAN, Ş. H., KURT, M. Y. (2022). Paclitaxel therapy and immune thrombocytopenic purpura: Coincidence or association?. Turkish Journal of Hematology, Cilt: 28 - Sayı: 2, 151–152. https://ajindex.com/articles/607010

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (4)

  1. Hillman RS, Ault KA, Rinder HM. Thrombocytopenia. In: Hematology in clinical practice. 4th ed. New. York: McGraw-Hill, 2005:339-56. Casciato DA. Hematologic complications. Casciato DA, Territo MC(Ed) Manual of clinical oncology. 6th ed. Lippincott Williams&Wilkins,2009:658-83. Solimando DA. Drug ınformation handbook for oncology. 6th ed. Lexİ- Comp Inc, 2007;804-9.
  2. Demirer T, Celebi H, Arat M, Ustün C, Demirer S, Dilek I, Ozcan M, Ilhan O, Akan H, Gürman G, Koç H. Autoimmune thrombocytopenia in a patient with small cell lung cancer developing after chemotherapy and resolving following autologous peripheral blood stem cell transplantation. Bone Marrow Transplant. 1999;24:335-7.
  3. Hackett T, Kelton JG, Powers P Drug-induced platelet destruction. Semin Thromb Hemost 1982;8:116-37.
  4. Rowinsky EK, Eisenhauer EA, Chaudhry V, Arbuck SG, Donehower RC. Clinical toxicities encountered with paclitaxel (Taxol). Semin Oncol. 1993;20:1-15.